RxDoctor Payments Data

Suhayb Kadura, MD

Interventional Cardiology · East Syracuse, NYNPI 1396163895

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 166 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 22.1% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,326, 2.3 times the $568 reported in 2021. That places this record below the midpoint for interventional cardiology clinicians in NY, where the typical reported total is $8,047.

$5,277in general payments, 2019–2025

Across 166 payments — averaging $31.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Philips North America LLC$1K
  • Edwards Lifesciences$1K
  • Abiomed$992
  • Abbott$503
  • AstraZeneca$232
  • Boston Scientific$222
  • plus $1K from 15 others

What the payments were for

  • Food & beverage$5,277100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,277 in reported general payments places this provider in the 35th percentile of 382 interventional cardiology providers in New York.

See all interventional cardiology providers in New York →

Medicare billing

Part B allowed, 2024
$153,569
Medicare patients
567
Services billed
1,289

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Metoprolol Succinate51$362
ClopidogrelClopidogrel Bisulfate99$347
Atorvastatin Calcium20$166
Ezetimibe12$138
Amlodipine Besylate21$64
Nitroglycerin12$50
Carvedilol13$46
Isosorbide Mononitrate ErIsosorbide Mononitrate16$40
Furosemide11$28
Metoprolol Tartrate13$21
Hydrochlorothiazide16$13

Paid to pharmacies, not to this prescriber.

Other interventional cardiology in East Syracuse

See the full list for New York →

Where these figures come from

Is this you, or does something look wrong? →